| | | | | | | | | | | |
| KOMISJA NADZORU FINANSOWEGO | |
| | | | | | | | | | | |
|
| | | Raport bieżący nr | 8 | / | 2023 | | | |
| | | | | | | | | | | |
| Data sporządzenia: | 2023-07-07 | | | | | | | | |
| | | | | | | | | |
| Skrócona nazwa emitenta | | | | | | | |
| MILESTONE MEDICAL | |
| | | | | | | | | | |
| Temat | | | | | | | | | | |
| Information on the date of the Annual Meeting of Shareholders | |
| Podstawa prawna | | | | | | | |
| Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bie ce i okresowe
| |
| | | | | | | | | | | |
| Treść raportu: | | | | | | | | | |
| The Board of Directors of Milestone Medical Inc. ("Company") informs that the Annual Meeting of Shareholders of the Company shall be held on Friday, September 1, 2023, at 9:00 am ET in Roseland, New Jersey, United States of America at the corporate office of the Company, located at 425 Eagle Rock Avenue, Suite 403. The record date for the notice of the meeting, the record date for voting, and the date of the determination of beneficial ownership shall be July 5, 2023.
Further information concerning the Meeting will be given by the Issuer by way of subsequent current reports and at the Company's website http://medicalmilestone.com/generalmeetingsofshareholders.html. | |
| | | | | | | | | | |
| Załączniki | | | | | | | | | | |
| Plik | Opis | |
| MMD_Announcement_AGM_2023.pdf | | |
| MMD_Draft_of_resolutions_AGM_2023.pdf | | |
| MMD_Proxy_Card_AGM_2023.pdf | | |
| | | | | | | | | | | |
| | | | | |
|
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | |
| 2023-07-07 | Keisha Harcum
| Controller
| Keisha Harcum | |
| | | | | |
